Pay in 4 interest-free payments of $32.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Levesque S
Bortezomib induces nuclear condensation at 16–24 hr after treatment
Smiles: CC(C)OC1=CC2[C@H](C3=CC=C(Cl)C=C3)N(C3=CC=C(C=C3)N(C)CC3CCC(CC3)N3CCN(C)C(=O)C3)C(=O)CC=2C=C1OC
PubMed PMID: 21933026
InChi: InChI=1S/C17H19FN4O4/c1-19-3-5-21(6-4-19)14-12(18)7-10-13-16(14)26-9-20(2)22(13)8-11(15(10)23)17(24)25/h7-8H
TRV130 Hydrochloride Catalog No.:M8468-10 Levesque STRV130 is a opioid receptor agonist, that is currently under evaluation in human clinical trials for the treatment of acute severe pain. TRV130 is a opioid receptor agonist, that is currently under evaluation in human clinical trials for the treatment of acute severe pain. Product information CAS Number: 1401031 39 7 Molecular Weight: 423. 01 Formula: C22H31ClN2O2S Synonym: Oliceridine hydrochloride TRV 130 hydrochloride Related CAS Number: 1401028 25
US$ 1543.50
US$ 1429.50
US$ 1167.00
US$ 1286.50
US$ 1106.50